Association of serum syndecan-1 concentrations with albuminuria in type 2 diabetes

被引：0
|
作者：
Kakutani, Yoshinori [1 ]
Morioka, Tomoaki [1 ]
Yamazaki, Yuko [1 ]
Ochi, Akinobu [1 ]
Fukumoto, Shinya [2 ]
Shoji, Tetsuo [3 ]
Emoto, Masanori [1 ]
机构：
[1] Osaka Metropolitan Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, 1-4-3 Asahi Machi,Abeno Ku, Osaka 5458585, Japan
[2] Osaka Metropolitan Univ, Grad Sch Med, Dept Premier Prevent Med, Osaka, Japan
[3] Osaka Metropolitan Univ, Grad Sch Med, Dept Vasc Med, Osaka, Japan
来源：
DIABETES & VASCULAR DISEASE RESEARCH | 2024年 / 21卷 / 04期
关键词：
Albuminuria; endothelial glycocalyx; syndecan-1; type; 2; diabetes; ENDOTHELIAL GLYCOCALYX; DEGRADATION; MELLITUS;
D O I：
10.1177/14791641241278362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: Syndecan (SDC)-1 is a transmembrane heparan sulfate proteoglycan and is a major component of endothelial glycocalyx (EG). This study aimed to investigate the association of serum SDC-1 concentration as a marker of EG degradation with albuminuria in type 2 diabetes. Methods: We included 370 patients with type 2 diabetes and 219 individuals with no diabetes. The individuals with estimate glomerular filtration rate <30 mL/min/1.73 m(2) were excluded. Results: Serum SDC-1 concentration was higher in type 2 diabetes than in no diabetes. The presence of diabetes was independently associated with log [SDC-1] in multivariate analysis. In type 2 diabetes, serum SDC-1 concentration was correlated with log [urinary albumin-to-creatinine ratio (ACR)]. Moreover, log [SDC-1] was an independent determinant of log [ACR] after adjustment for known risk factors of albuminuria. Conclusions: Serum SDC-1 concentration was higher in patients with type 2 diabetes compared to individuals with no diabetes and an independent determinant of ACR. This study implicates the role of the EG degradation in albuminuria in type 2 diabetes.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Study of association of serum uric acid with albuminuria and carotid atherosclerosis in type 2 diabetes mellitus patients
    Singh, Kuldeep
    Kumar, Pardeep
    Joshi, Arun
    Shivhare, Dileep Kumar
    Mahto, Subodh Kumar
    Singh, Akanskha
    Aneja, Ankita
    Lamba, Brinder Mohan Singh
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (12) : 4027 - 4031
  • [42] Serum hepcidin concentrations and type 2 diabetes
    Aregbesola, Alex
    Voutilainen, Sari
    Virtanen, Jyrki K.
    Aregbesola, Adeola
    Tuomainen, Tomi-Pekka
    WORLD JOURNAL OF DIABETES, 2015, 6 (07) : 978 - 982
  • [43] RELATIONSHIP BETWEEN ALBUMINURIA AND SERUM LIPIDS IN TYPE 1 DIABETES MELLITUS
    Bulum, T.
    Prkacin, I.
    Duvnjak, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 51 - 51
  • [44] Serum syndecan-1 reflects organ dysfunction in critically ill patients
    Keiko Suzuki
    Hideshi Okada
    Kazuyuki Sumi
    Hiroyuki Tomita
    Ryo Kobayashi
    Takuma Ishihara
    Yoshinori Kakino
    Kodai Suzuki
    Naomasa Yoshiyama
    Ryu Yasuda
    Yuichiro Kitagawa
    Tetsuya Fukuta
    Takahito Miyake
    Haruka Okamoto
    Tomoaki Doi
    Takahiro Yoshida
    Shozo Yoshida
    Shinji Ogura
    Akio Suzuki
    Scientific Reports, 11
  • [45] SERUM LEVELS OF SYNDECAN-1 AND ORGAN INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Fajardo-Robledo, N.
    Diaz-Rizo, V.
    Rocha-Munoz, A.
    Munoz-Valle, J.
    Gonzalez-Lopez, L.
    Gamez-Nava, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 831 - 832
  • [46] Assessment of syndecan-1 as a novel serum biomarker for monitoring eosinophilic esophagitis
    Philpott, H.
    Dellon, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 171 - 171
  • [47] Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis
    Yu, Kelvin Y. C.
    Yung, Susan
    Chau, Mel K. M.
    Tang, Colin S. O.
    Yap, Desmond Y. H.
    Tang, Alexander H. N.
    Ying, Shirley K. Y.
    Lee, Cheuk Kwong
    Chan, Tak Mao
    RHEUMATOLOGY, 2021, 60 (02) : 737 - 750
  • [48] Serum syndecan-1: a new independent prognostic marker in multiple myeloma
    Seidel, C
    Sundan, A
    Hjorth, M
    Turesson, I
    Dahl, IMS
    Abildgaard, N
    Waage, A
    Borset, M
    BLOOD, 2000, 95 (02) : 388 - 392
  • [49] Serum Syndecan-1 In Patients With Acute Exacerbation Of Idiopathic Interstitial Pneumonia
    Togawa, R.
    Tanino, Y.
    Nikaido, T.
    Misa, K.
    Sato, Y.
    Suzuki, Y.
    Uematsu, M.
    Fukuhara, A.
    Sato, S.
    Saito, J.
    Wang, X.
    Munakata, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [50] Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
    Deyab, Gia
    Reine, Trine Marita
    Tram Thu Vuong
    Jenssen, Trond
    Hjeltnes, Gunnbjorg
    Agewall, Stefan
    Mikkelsen, Knut
    Forre, Oystein
    Fagerland, Morten Wang
    Kolset, Svein Olav
    Hollan, Ivana
    PLOS ONE, 2021, 16 (07): : e0253247
12345